SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 9, 2003
HALSEY DRUG CO., INC.
695 North Perryville Road, Rockford, Illinois 61107
(815-399-2060)
Incorporated under the Commission File Number I.R.S. Employer
laws of State of New York 1-10113 Identification Number
11-0853640
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit
Number Description
------ -----------
99.1 Press Release of Halsey Drug Co., Inc.
dated May 9, 2003 reporting results
for the year ended December 31, 2002.
Item 9. Regulation FD Disclosure.
The Registrant is furnishing under Item 9 of this Current Report on
Form 8-K:
(i) Exhibit 99.1 consisting of a copy of the press release
issued on May 9, 2003 reporting results for the year ended
December 31, 2002.
The statements in this Current Report on Form 8-K, including the
exhibits, contain forward-looking statements and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that forward-looking statements involve risk and
uncertainties which may affect the Registrant's business prospects, including,
economic, competitive, governmental, technological and other factors discussed
in filings with the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HALSEY DRUG CO., INC.
By: /s/ Peter A. Clemens
-----------------------------------------
Peter A. Clemens
Vice President & Chief Financial Officer
Date: May 9, 2003
EXHIBIT INDEX
-------------
Exhibit
Number Description
------ -----------
99.1 Press Release of Halsey Drug Co., Inc.
dated May 9, 2003 reporting results
for the forth quarter and year ended
December 31, 2002.